Central adrenal insufficiency in children and adolescents

Giuseppa Patti, Chiara Guzzeti, Natascia Di Iorgi, Anna Elsa Maria Allegri, Flavia Napoli, Sandro Loche, Mohamad Maghnie

Research output: Contribution to journalReview article

Abstract

Central adrenal insufficiency (CAI) is a life-threatening condition caused by either pituitary disease (secondary adrenal insufficiency) or impaired hypothalamic function with inadequate CRH production (tertiary adrenal insufficiency). ACTH deficiency may be isolated or, more frequently, occur in conjunction with other pituitary hormone deficiencies and midline defects. Genetic mutations of the TBX19 causing isolated CAI are rare but a number of genes encoding transcription factors involved in hypothalamic-pituitary gland development, as well as other genes including POMC and PC1, are associated with ACTH deficiency. CAI is frequently identified in congenital, malformative, genetic, and epigenetic syndromes as well as in several acquired conditions of different etiologies. The signs and symptoms vary considerably and depend on the age of onset and the number and severity of associated pituitary defects. They may include hypoglycemia, lethargy, apnea, poor feeding, prolonged cholestatic jaundice, jitteriness, seizures, and sepsis in the neonate, or nonspecific signs such as fatigue, hypotension, vomiting and hyponatremia without hyperkalemia in children. The diagnosis of CAI relies on the measurement of morning cortisol concentrations along with dynamic test for cortisol release with different stimulating agents. Early recognition of CAI and its correct management are mandatory in order to avoid both morbidity and mortality in affected neonates, children and adolescents.

Original languageEnglish
Pages (from-to)425-444
Number of pages20
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Volume32
Issue number4
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Adrenal Insufficiency
Adrenocorticotropic Hormone
Hydrocortisone
Newborn Infant
Pituitary Diseases
Pro-Opiomelanocortin
Lethargy
Hyperkalemia
Pituitary Hormones
Obstructive Jaundice
Hyponatremia
Apnea
Pituitary Gland
Age of Onset
Hypoglycemia
Epigenomics
Hypotension
Genes
Signs and Symptoms
Vomiting

Keywords

  • ACTH
  • central adrenal insufficiency
  • cortisol
  • diagnosis
  • treatment

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Central adrenal insufficiency in children and adolescents. / Patti, Giuseppa; Guzzeti, Chiara; Di Iorgi, Natascia; Maria Allegri, Anna Elsa; Napoli, Flavia; Loche, Sandro; Maghnie, Mohamad.

In: Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 32, No. 4, 01.08.2018, p. 425-444.

Research output: Contribution to journalReview article

@article{c4934e1688904b8bbfa93449c5a685bc,
title = "Central adrenal insufficiency in children and adolescents",
abstract = "Central adrenal insufficiency (CAI) is a life-threatening condition caused by either pituitary disease (secondary adrenal insufficiency) or impaired hypothalamic function with inadequate CRH production (tertiary adrenal insufficiency). ACTH deficiency may be isolated or, more frequently, occur in conjunction with other pituitary hormone deficiencies and midline defects. Genetic mutations of the TBX19 causing isolated CAI are rare but a number of genes encoding transcription factors involved in hypothalamic-pituitary gland development, as well as other genes including POMC and PC1, are associated with ACTH deficiency. CAI is frequently identified in congenital, malformative, genetic, and epigenetic syndromes as well as in several acquired conditions of different etiologies. The signs and symptoms vary considerably and depend on the age of onset and the number and severity of associated pituitary defects. They may include hypoglycemia, lethargy, apnea, poor feeding, prolonged cholestatic jaundice, jitteriness, seizures, and sepsis in the neonate, or nonspecific signs such as fatigue, hypotension, vomiting and hyponatremia without hyperkalemia in children. The diagnosis of CAI relies on the measurement of morning cortisol concentrations along with dynamic test for cortisol release with different stimulating agents. Early recognition of CAI and its correct management are mandatory in order to avoid both morbidity and mortality in affected neonates, children and adolescents.",
keywords = "ACTH, central adrenal insufficiency, cortisol, diagnosis, treatment",
author = "Giuseppa Patti and Chiara Guzzeti and {Di Iorgi}, Natascia and {Maria Allegri}, {Anna Elsa} and Flavia Napoli and Sandro Loche and Mohamad Maghnie",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.beem.2018.03.012",
language = "English",
volume = "32",
pages = "425--444",
journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",
issn = "1521-690X",
publisher = "Bailliere Tindall Ltd",
number = "4",

}

TY - JOUR

T1 - Central adrenal insufficiency in children and adolescents

AU - Patti, Giuseppa

AU - Guzzeti, Chiara

AU - Di Iorgi, Natascia

AU - Maria Allegri, Anna Elsa

AU - Napoli, Flavia

AU - Loche, Sandro

AU - Maghnie, Mohamad

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Central adrenal insufficiency (CAI) is a life-threatening condition caused by either pituitary disease (secondary adrenal insufficiency) or impaired hypothalamic function with inadequate CRH production (tertiary adrenal insufficiency). ACTH deficiency may be isolated or, more frequently, occur in conjunction with other pituitary hormone deficiencies and midline defects. Genetic mutations of the TBX19 causing isolated CAI are rare but a number of genes encoding transcription factors involved in hypothalamic-pituitary gland development, as well as other genes including POMC and PC1, are associated with ACTH deficiency. CAI is frequently identified in congenital, malformative, genetic, and epigenetic syndromes as well as in several acquired conditions of different etiologies. The signs and symptoms vary considerably and depend on the age of onset and the number and severity of associated pituitary defects. They may include hypoglycemia, lethargy, apnea, poor feeding, prolonged cholestatic jaundice, jitteriness, seizures, and sepsis in the neonate, or nonspecific signs such as fatigue, hypotension, vomiting and hyponatremia without hyperkalemia in children. The diagnosis of CAI relies on the measurement of morning cortisol concentrations along with dynamic test for cortisol release with different stimulating agents. Early recognition of CAI and its correct management are mandatory in order to avoid both morbidity and mortality in affected neonates, children and adolescents.

AB - Central adrenal insufficiency (CAI) is a life-threatening condition caused by either pituitary disease (secondary adrenal insufficiency) or impaired hypothalamic function with inadequate CRH production (tertiary adrenal insufficiency). ACTH deficiency may be isolated or, more frequently, occur in conjunction with other pituitary hormone deficiencies and midline defects. Genetic mutations of the TBX19 causing isolated CAI are rare but a number of genes encoding transcription factors involved in hypothalamic-pituitary gland development, as well as other genes including POMC and PC1, are associated with ACTH deficiency. CAI is frequently identified in congenital, malformative, genetic, and epigenetic syndromes as well as in several acquired conditions of different etiologies. The signs and symptoms vary considerably and depend on the age of onset and the number and severity of associated pituitary defects. They may include hypoglycemia, lethargy, apnea, poor feeding, prolonged cholestatic jaundice, jitteriness, seizures, and sepsis in the neonate, or nonspecific signs such as fatigue, hypotension, vomiting and hyponatremia without hyperkalemia in children. The diagnosis of CAI relies on the measurement of morning cortisol concentrations along with dynamic test for cortisol release with different stimulating agents. Early recognition of CAI and its correct management are mandatory in order to avoid both morbidity and mortality in affected neonates, children and adolescents.

KW - ACTH

KW - central adrenal insufficiency

KW - cortisol

KW - diagnosis

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85046147048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046147048&partnerID=8YFLogxK

U2 - 10.1016/j.beem.2018.03.012

DO - 10.1016/j.beem.2018.03.012

M3 - Review article

C2 - 30086867

AN - SCOPUS:85046147048

VL - 32

SP - 425

EP - 444

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

SN - 1521-690X

IS - 4

ER -